Are There Warning Signs About Moderna's COVID-19 Vaccine Program?
In any discussion about the race to develop a vaccine against the novel coronavirus that causes COVID-19, Moderna (NASDAQ: MRNA) will almost certainly be mentioned. The biotech ranked among a select group of companies to receive significant funding as part of Operation Warp Speed, the U.S. government program created to accelerate COVID-19 vaccine development. It is without question one of the clear leaders in developing a COVID-19 vaccine candidate.
But how are Moderna's efforts really going behind the scenes? A recent report from Reuters highlighted some potential issues with the biotech's COVID-19 vaccine program. Are there warnings signs that investors should be worried about?
Image source: Getty Images.
Source Fool.com
